Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Marks First Telehealth Awareness Week

Executive Summary

US lawmakers issued a bipartisan resolution in recognition of the first Telehealth Awareness Week sponsored by the American Telemedicine Association. The resolution illustrates telehealth’s broad support and appeal.

You may also be interested in...



Telehealth Study Rates All 50 States On Patient Access To Virtual Care

Several US states hit hardest by COVID-19 have the most restrictive telehealth laws, according to a report from the Reason Foundation, Cicero Institute and Pioneer Institute. As telehealth becomes more integrated into the country’s health care system, states should adopt more reforms so residents can benefit from the advancing technology, the report urges. 

Biden Admin Looks To Broaden Telehealth, Increase Access To Mental Health Care

Proposals from the US Centers for Medicare & Medicaid Services (CMS) would help make telehealth a permanent fixture across the healthcare landscape, particularly for treating mental health.

House Funding Bill Increases Investment In Rural Broadband, Ups FDA Budget

Broadband for rural communities is a top priority in legislation from the US House Appropriations Committee. The funding bill also provides $3.45bn for the US Food and Drug Administration.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT144501

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel